- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04461821
Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents (EBECA)
Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents (EBECA)
Study Overview
Status
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Pablo Sinues, Prof. Dr.
- Phone Number: +41 61 704 2949
- Email: pablo.sinues@ukbb.ch
Study Contact Backup
- Name: Mélina Richard
- Phone Number: +41 61 704 14 11
- Email: melinadenise.richard@unibas.ch
Study Locations
-
-
-
Basel, Switzerland, 4031
- Recruiting
- University Children's Hospital Basel (UKBB)
-
Contact:
- Pablo Sinues, Prof. Dr.
- Phone Number: +41 61 704 2949
- Email: pablo.sinues@ukbb.ch
-
Contact:
- Mélina Richard
- Phone Number: +41 61 704 14 11
- Email: melinadenise.richard@unibas.ch
-
Sub-Investigator:
- J Usemann, Dr. med.
-
Sub-Investigator:
- U Fray, Prof. Dr. med.
-
Sub-Investigator:
- A Datta, PD Dr. med.
-
Sub-Investigator:
- G Szinnai, PD Dr. med.
-
Sub-Investigator:
- A Jochmann, Dr. med.
-
Sub-Investigator:
- T Erb, Prof. Dr. med.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Participants presenting with an acute disease in the emergency department at the University of Basel Children's Hospital (UKBB).
Participants with chronic diseases recorded at the University of Basel Children's Hospital (UKBB).
Description
Inclusion Criteria:
- Age 0 ≤ 22 years at study entry and signed informed consent
Additional inclusion criteria for respiratory disease population:
- Acute disease: - Acute signs for a respiratory disease, indicated by e.g. increased work of breathing (e.g. dyspnea, increased respiratory rate), cough or wheezing.
- Chronic disease: - Suspected or confirmed chronic airway disease (e.g. asthma).
Additional inclusion criteria for neurological disease population:
- Acute disease: - Acute presentation or report within 24 hours of any signs of neurological deficit (motor function, sensoneural, or verbal).
- Chronic disease: - Confirmed chronic neurologic disease (e.g. childhood epilepsy).
Additional inclusion criteria for T1D disease population:
- Acute disease: - Hyperglycemia and/or pH (venous) <7.3, bicarbonate >10 mmol/L, increased levels of acetone in blood or urine in the context of newly diagnosed or known T1D.
- Chronic disease: - Confirmed diagnosis of T1D
Exclusion Criteria:
- Physical or intellectual impairment precluding protocol adherence.
Additional exclusion criteria for respiratory disease population:
- Known malignancy, active smoker (passive smoke exposure is not an exclusion criterium), known inflammatory diseases (e.g. autoimmune disease) that require medical and/or pharmacological treatment and is associated with an inflammatory response, relevant congenital defects
Additional exclusion criteria for neurological disease population:
- Known malignancy, active smoker (passive smoke exposure is not an exclusion criterium), known inflammatory diseases (e.g. autoimmune disease) that require medical and/or pharmacological treatment and is associated with an inflammatory response, relevant congenital defects.
Additional exclusion criteria for T1D population:
- Known malignancy, active smoker (passive smoke exposure is not an exclusion criterium), relevant congenital defects.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
asthma
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
obstructive bronchitis/bronchiolitis
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
pneumonia
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
neurological diseases
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
type 1 diabetes (T1D)
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
During the diagnostic and therapeutic work-up of T1D patients, saliva samples are collected during the clinical routine.
For those patients, additional samples will be obtained by clinically trained investigators.
During the diagnostic and therapeutic work-up of T1D patients, urine samples are collected during the clinical routine.
For those patients, additional samples will be obtained by clinically trained investigators.
|
pharmacotherapy with bronchodilators
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
pharmacotherapy with antibiotics
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
pharmacotherapy with antiviral medication
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
pharmacotherapy with antifungal medication
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
pharmacotherapy with antiepileptic medication
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
pharmacotherapy with immuno suppressants and immune-modulati
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
pharmacotherapy with anesthesia (including sedating, analges
|
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed.
Room temperature and lighting will be set at the same level for all measurements.
Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain).
While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer.
Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode).
The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line.
They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis.
Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls.
This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale.
For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line.
No additional venous puncture for research purpose will be done.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Days of hospitalization
Time Frame: approx 30 days (from beginn hospitalisation to discharge date)
|
In the presentation of an acute disease the primary outcome will be days of hospitalization and its association with the exhaled breath pattern.
|
approx 30 days (from beginn hospitalisation to discharge date)
|
Change in Mass spectrometric profile of exhaled breath patterns
Time Frame: Week 0 (first regular clinic visit) to Follow-up visits (approx. years 1-10)
|
In the chronic presentation of the diseases, the mass spectrometric profile of exhaled breath patterns is analyzed
|
Week 0 (first regular clinic visit) to Follow-up visits (approx. years 1-10)
|
Change in Concentration of exhaled metabolites of pharmacotherapy
Time Frame: Week 0 (first regular clinic visit) to Follow-up visits (approx. years 1-10)
|
Concentration of exhaled metabolites of pharmacotherapy (breath metabolomics data)
|
Week 0 (first regular clinic visit) to Follow-up visits (approx. years 1-10)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Identification of chemical structure of exhaled molecules (acetone, glucose)
Time Frame: approx 30 days (from begin hospitalisation to discharge date)
|
Identification of chemical structure of exhaled molecules (acetone, glucose)
|
approx 30 days (from begin hospitalisation to discharge date)
|
Correlations of identified molecules (acetone, glucose) in exhaled breath with body fluids (blood, saliva, urine) for T1D acute disease (mmol/l)
Time Frame: 0h, 2h, 4h, 6h, 8h, 12h, 18h, 24h, 36h, 48h, 72h (h =hours after hospital admission)
|
Correlations of identified molecules (acetone, glucose) in exhaled breath with body fluids (blood, saliva, urine) for T1D acute disease (mmol/l)
|
0h, 2h, 4h, 6h, 8h, 12h, 18h, 24h, 36h, 48h, 72h (h =hours after hospital admission)
|
Change in clinical endpoint lung function (Forced Expiratory Pressure in 1 Second FEV1 l/s) for correlation between clinical endpoint and the abundance of exhaled metabolites
Time Frame: approx 10 years (from begin hospitalisation to discharge date and from first regular clinic visit to Follow-up visits)
|
Change in clinical endpoint lung function (Forced Expiratory Pressure in 1 Second FEV1 l/s) for correlation between clinical endpoint and the abundance of exhaled metabolites
|
approx 10 years (from begin hospitalisation to discharge date and from first regular clinic visit to Follow-up visits)
|
Change in clinical endpoint (body temperature, Celsius) for correlation between clinical endpoint and the abundance of exhaled metabolites
Time Frame: approx 10 years (from begin hospitalisation to discharge date and from first regular clinic visit to Follow-up visits)
|
Change in clinical endpoint (body temperature) for correlation between clinical endpoint and the abundance of exhaled metabolites
|
approx 10 years (from begin hospitalisation to discharge date and from first regular clinic visit to Follow-up visits)
|
Change in clinical endpoint (blood pressure, mmHg) for correlation between clinical endpoint and the abundance of exhaled metabolites
Time Frame: approx 10 years (from begin hospitalisation to discharge date and from first regular clinic visit to Follow-up visits)
|
Change in clinical endpoint (blood pressure) for correlation between clinical endpoint and the abundance of exhaled metabolites
|
approx 10 years (from begin hospitalisation to discharge date and from first regular clinic visit to Follow-up visits)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pablo Sinues, Prof. Dr., University Children's Hospital Basel, UKBB
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-00778; ks20Sinues
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on Real-time SESI-MS breath analysis
-
Fondation LenvalWithdrawn
-
IRCCS Eugenio MedeaRecruitingCerebral Palsy | Acquired Brain InjuryItaly
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Assiut UniversityUnknownAcute Myeloid Leukemia
-
Assiut UniversityUnknownAutism Spectrum Disorder
-
Seoul St. Mary's HospitalBristol-Myers SquibbRecruitingChronic Myelocytic LeukemiaKorea, Republic of
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WithdrawnHead and Neck CancerUnited States
-
Assiut UniversityScience and Technology Development Fund (STDF)CompletedMyocarditis ViralEgypt
-
Hungarian Institute of CardiologyUnknownCardiopulmonary Resuscitation
-
Assiut UniversityUnknownViral MyocarditisEgypt